UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000000598
Receipt number R000000725
Scientific Title Adjuvant Chemotherapy With Gemcitabine in Patients Undergoing Curative-Intent Resection of Biliary Cancer: a Phase I/II Trial
Date of disclosure of the study information 2007/02/07
Last modified on 2011/02/26 06:55:31

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Adjuvant Chemotherapy With Gemcitabine in Patients Undergoing Curative-Intent Resection of Biliary Cancer: a Phase I/II Trial

Acronym

Adjuvant Chemotherapy With Gemcitabine in Biliary Cancer

Scientific Title

Adjuvant Chemotherapy With Gemcitabine in Patients Undergoing Curative-Intent Resection of Biliary Cancer: a Phase I/II Trial

Scientific Title:Acronym

Adjuvant Chemotherapy With Gemcitabine in Biliary Cancer

Region

Japan


Condition

Condition

Biliary Cancer

Classification by specialty

Hepato-biliary-pancreatic medicine Hepato-biliary-pancreatic surgery

Classification by malignancy

Malignancy

Genomic information

NO


Objectives

Narrative objectives1

To determine the safety and efficacy of a postoperative regimen with gemcitabine in patients undergoing curative-intent resection of biliary cancer

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1

Confirmatory

Trial characteristics_2

Pragmatic

Developmental phase

Phase I,II


Assessment

Primary outcomes

Phase I: Safety
Phase II: Feasibility

Key secondary outcomes

Phase II: Safety


Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Uncontrolled

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Treatment

Type of intervention

Medicine

Interventions/Control_1

Adjuvant chemotherapy with 6 cycles of gemcitabine on days 1, 8, and 15 every 4 weeks

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

75 years-old >

Gender

Male and Female

Key inclusion criteria

Patients with histologically verified biliary cancer who had macroscopic complete resection (>=stage II) and no prior radiation or chemotherapy
ECOG Performance Status 0-1
Adequate organ function (leukocytes>=4.0 X 109/L, neutrophils>=2.0 X 109/L, platelets>=100 X 109/L, hemoglobin>=9 g/dl, total bilirubin<=2 X upper limit of normal (ULN), AST, ALT<=4 X ULN, serum creatine<=ULN
No fever with infection
Adverse events other than blood/bone marrow<=grade 2 according to National Cancer Institute - Common Terminology Criteria for Adverse Events v3.0
Written informed consent
No major postoperative complication
Tolerable to chemotherapy within 12 weeks after surgery

Key exclusion criteria

Pulmonary fibrosis or interstitial pneumonia with radiological or clinical findings
Uncontrollable pleural effusion
Uncontrollable diabetes mellitus or liver dysfunction
With distant metastasis except lymph node metastasis
With uncured other malignancies
Active infection
Severe major postoperative complication such as peritonitis and massive bleeding
With active peptic ulcer
A history of myocardial infarction within 3 months
Psychiatric disorder
Pregnant or breast-feeding women, Women wishing for baby

Target sample size

26


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Etsuro Hatano

Organization

Graduate School of Medicine
Kyoto University

Division name

Department of Surgery

Zip code


Address

54 Kawaharacho Shogoin Sakyoku Kyoto

TEL

075-751-3234

Email



Public contact

Name of contact person

1st name
Middle name
Last name Etsuro Hatano

Organization

Graduate School of Medicine

Division name

Department of Surgery

Zip code


Address

54 Kawaharacho Shogoin Sakyoku Kyoto

TEL

075-751-3234

Homepage URL


Email

etsu@kuhp.kyoto-u.ac.jp


Sponsor or person

Institute

Department of Surgery
Graduate School of Medicine
Kyoto University

Institute

Department

Personal name



Funding Source

Organization

Department of Surgery
Graduate School of Medicine
Kyoto University

Organization

Division

Category of Funding Organization

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2007 Year 02 Month 07 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2007 Year 01 Month 27 Day

Date of IRB


Anticipated trial start date

2007 Year 02 Month 01 Day

Last follow-up date

2011 Year 01 Month 01 Day

Date of closure to data entry

2011 Year 01 Month 01 Day

Date trial data considered complete

2011 Year 01 Month 01 Day

Date analysis concluded

2011 Year 01 Month 01 Day


Other

Other related information



Management information

Registered date

2007 Year 02 Month 07 Day

Last modified on

2011 Year 02 Month 26 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000000725


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name